Search our site
Contact us for epilepsy information and support

Categories

Medicinal Cannabis and Epilepsy

Medicinal Cannabis and Epilepsy Syndromes

Medicinal Cannabis Studies

Medicinal Cannabis in Australia

Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents – an observational, longitudinal study

Hausman-Kedem M, Menascu S, Kramer U.

Brain and Development Aug 2018 (Abstract)

Medicinal Cannabis and Epilepsy

Therapeutic Use of medicinal cannabis in difficult to manage epilepsy

John A Lawson and Ingrid E Scheffer

British Journal of Clinical Pharmacology Aug 2018 (Article)

Medicinal Cannabis and Epilepsy

Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results

Szaflarski JP, Bebin EM, Comi AM, Patel AD, Joshi C, Checketts D, Beal JC, Laux LC, De Boer LM, Wong MH, Lopez M, Devinsky O, Lyons PD, Zentil PP and Wechsler R

Epilepsia Aug 2018 (Article)

Medicinal Cannabis and Epilepsy

Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community

A. Suraev, N. Lintzeris, J. Stuart, R. C. Kevin, R. Blackburn, E. Richards, J. C. Arnold, C. Ireland, L. Todd, D. J. Allsop & I. McGregor

Scientific Reports Jul 2018 (Article)

Medicinal Cannabis and Epilepsy

Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence

Emily Stockings, Dino Zagic, Gabrielle Campbell, Megan Weier, Wayne D Hall, Suzanne Nielsen, Geoffrey K Herkes, Michael Farrell, Louisa Degenhardt

Journal of Neurology & Neurosurgical Psychiatry Mar 2018 (Article)

Medicinal Cannabis and Epilepsy

Interactions between cannabidiol and commonly used antiepileptic drugs

Gaston TE, Bebin EM, Cutter GR, Liu Y and Szaflarski JP

Epilepsia Sep 2017 (Article)

Medicinal Cannabis and Epilepsy

An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use

Suraev AS, Todd L, Bowen MT, Allsop DJ, McGregor IS, Ireland C and Lintzeris N

Epilepsy & Behavior May 2017 (Article)

Medicinal Cannabis and Epilepsy

Pharmacology of cannabinoids in the treatment of epilepsy

Gaston TE and Friedman D

Epilepsy & Behavior May 2017 (Abstract)

Medicinal Cannabis and Epilepsy

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, Miller I, Flamini R, Wilfong A, Filloux F, Wong M, Tilton N, Bruno P, Bluvstein J, Hedlund J, Kamens R, Maclean J, Nangia S, Singhal NS, Wilson CA, Patel A, Cilio MR

The Lancet Neurology Mar 2016 (Abstract)

Medicinal Cannabis and Epilepsy

CBD-enriched medical cannabis for intractable pediatric epilepsy: the current Israeli experience

Tzadok M, Uliel-Siboni S, Linder I, Kramer U, Epstein O, Menascu S, et al.

Seizure Feb 2016 (Article)

Medicinal Cannabis and Epilepsy

Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy

Geffrey AL, Pollack SF, Bruno PL and Thiele EA

Epilepsia: Aug 2015 (Article)

Medicinal Cannabis and Epilepsy

Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox-Gastaut Syndrome: A Systematic Review and Meta-Analysis

Lattanzi S, Brigo F, Cagnetti C, Trinka E and Silvestrini M

CNS Drugs Oct 2018 (Abstract)

Medicinal Cannabis and Epilepsy Syndromes

Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes.

Devinsky O, Verducci C, Thiele EA, Laux LC, Patel AD, Filloux F, Szaflarski JP, Wilfong A, Clark GD, Park YD, Seltzer LE, Bebin EM, Flamini R, Wechsler RT and Friedman D

Epilepsy & Behavior Sep 2018 (Article)

Medicinal Cannabis and Epilepsy Syndromes

Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome

Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, Greenwood SM, Roberts C, Checketts D, Van Landingham KE and Zuberi SM

New England Journal of Medicine May 2018 (Abstract)

Medicinal Cannabis and Epilepsy Syndromes

Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.

Devinsky O, Patel AD, Thiele EA, Wong MH, Appleton R, Harden CL, Greenwood S, Morrison G and Sommerville K

Neurology Apr 2018 (Article)

Medicinal Cannabis and Epilepsy Syndromes

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA and Wright S

New England Journal of Medicine May 2017 (Article)

Medicinal Cannabis and Epilepsy Syndromes

Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex

Hess EJ, Moody KA, Geffrey AL, Pollack SF, Skirvin LA, Bruno PL, Paolini JL and Thiele EA.

Epilepsia Oct 2016 (Article)

Medicinal Cannabis and Epilepsy Syndromes

The pharmacokinetics and the pharmacodynamics of cannabinoids

Catherine J. Lucas, Peter Galettis and Jennifer Schneider

British Journal of Clinical Pharmacology Jul 2018 (Article)

Medicinal Cannabis Studies

Medical cannabis: aligning use to evidence‐based medicine approach

Lihi Bar‐Lev Schleider, Ran Abuhasira and Victor Novack

British Journal of Clinical Pharmacology Jun 2018 (Article)

Medicinal Cannabis Studies

Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects

Laura M. Dryburgh, Nanthi S. Bolan, Christopher P.L. Grof, Peter Galettis, Jennifer Schneider, Catherine J. Lucas and Jennifer H. Martin

British Journal of Clinical Pharmacology Jun 2018 (Article)

Medicinal Cannabis Studies

Cannabis, from plant to pill

Christopher P. L. Grof

British Journal of Clinical Pharmacology Apr 2018 (Article)

Medicinal Cannabis Studies

Labeling Accuracy of Cannabidiol Extracts Sold Online

Marcel O. Bonn-Miller, Mallory J. E. Loflin, Brian F. Thomas, Jahan P. Marcu, Travis Hyke and Ryan Vandrey

JAMA Nov 2017 (Article)

Medicinal Cannabis Studies

Tetrahydrocannabinolic acid (THCa) is a potent PPARγ agonist with neuroprotective activity

Xavier Nadal, Carmen del Río, Salvatore Casano, Belén Palomares, Carlos Ferreiro‐Vera, Carmen Navarrete, Carolina Sánchez‐Carnerero, Irene Cantarero, Maria Luz Bellido, Stefan Meyer, Gaetano Morello, Giovanni Appendino and Eduardo Muñoz

British Journal of Clinical Pharmacology Aug 2017 (Abstract)

Medicinal Cannabis Studies

Towards a better cannabis drug

Raphael Mechoulam and Linda Parker

British Journal of Clinical Pharmacology Sep 2013 (Article)

Medicinal Cannabis Studies

Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16)

Nicholas Lintzeris, Jessica Driels, Natalie Elias, Jonathon C Arnold, Iain S McGregor and David J Allsop

Medical Journal of Australia Sep 2018 (Article)

Medicinal Cannabis in Australia

Medicinal Cannabis and the Tyranny of Distance: Policy Reform Required for Optimizing Patient and Health System Net Benefit in Australia

David Caldicott, Justin Sinclair, Lynnaire Sheridan and Simon Eckermann

Applied Health Economics and Health Policy Apr 2018 (Article)

Medicinal Cannabis in Australia

Coming Soon